Co-Founder, Chairman, CEO

Chief Commercial Officer (CCO)

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review

Certain Common Stock of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Certain Pre-Funded Warrants of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Associate Director, Clinical Scientist

Celcuity is a clinical-stage biotechnology company focused on developing targeted therapies for cancer treatment. The Associate Director, Clinical Scientist will be responsible for executing Clinical Development goals and collaborating with Medical Directors and other departments to ensure high-quality clinical documents and data integrity.

Sign up with Google

Sign in with Google